CTOs on the Move

Sirnaomics

www.sirnaomics.com

 
Sirnaomics, Inc. is a biopharmaceutical company discovering and developing novel targeted therapeutics for critical human diseases by using RNA interference (RNAi) technology.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.sirnaomics.com
  • 401 Professional Drive Suite 280
    Gaithersburg, MD USA 20879
  • Phone: 301.740.1730

Executives

Name Title Contact Details
Dmitry Samarsky
Chief Technology Officer Profile

Funding

Sirnaomics raised $25M on 06/05/2018
Sirnaomics raised $11M on 01/11/2019
Sirnaomics raised $22M on 04/29/2019
Sirnaomics raised $105M on 10/23/2020
Sirnaomics raised $105M on 07/01/2021

Similar Companies

PuraMed

PuraMed is a Schofield, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biorasi

Biorasi is an award-winning full service, global Clinical Research Optimized (CRO). From project design to execution success, optimization is engrained in ProAct+. An integrated platform of high performance systems, tools, and processes. By developing and implementing groundbreaking methods of optimizing clinical research, we contribute to enhancement of health and well-being for people around the world.    Powered by ProAct+, Biorasi`s full service project teams have developed numerous drugs, biologics and devices that received FDA and multi-venue approvals. Biorasi is headquartered in Miami, FL and has regional operations around the world.

Sunovion Pharmaceuticals

Sunovion Pharmaceuticals Inc., known until October 12, 2010 as Sepracor, Inc.

MRXI Corporation

MRXI Corporation is a Downers Grove, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aurobindo Pharma USA

Aurobindo USA is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients. Since its first US ANDA approval in 2004, Aurobindo has expanded its portfolio to include more than 125 product families and 450 individual product packages, representing a wide range of therapeutic categories. Aurobindo has been recognized as the fastest growing pharmaceutical company in 2012,* and in early 2013, thanks to the ongoing support of our customers, became one of the top 10 pharmaceutical companies, brand or generic, in terms of total prescriptions dispensed.**